With 74% institutional ownership, ResMed Inc. (NYSE:RMD) is a favorite amongst the big guns

In This Article:

Key Insights

  • Given the large stake in the stock by institutions, ResMed's stock price might be vulnerable to their trading decisions

  • The top 20 shareholders own 50% of the company

  • Insiders have sold recently

Every investor in ResMed Inc. (NYSE:RMD) should be aware of the most powerful shareholder groups. With 74% stake, institutions possess the maximum shares in the company. In other words, the group stands to gain the most (or lose the most) from their investment into the company.

Given the vast amount of money and research capacities at their disposal, institutional ownership tends to carry a lot of weight, especially with individual investors. As a result, a sizeable amount of institutional money invested in a firm is generally viewed as a positive attribute.

Let's delve deeper into each type of owner of ResMed, beginning with the chart below.

See our latest analysis for ResMed

ownership-breakdown
NYSE:RMD Ownership Breakdown December 18th 2024

What Does The Institutional Ownership Tell Us About ResMed?

Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.

As you can see, institutional investors have a fair amount of stake in ResMed. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at ResMed's earnings history below. Of course, the future is what really matters.

earnings-and-revenue-growth
NYSE:RMD Earnings and Revenue Growth December 18th 2024

Investors should note that institutions actually own more than half the company, so they can collectively wield significant power. ResMed is not owned by hedge funds. Our data shows that The Vanguard Group, Inc. is the largest shareholder with 14% of shares outstanding. For context, the second largest shareholder holds about 8.4% of the shares outstanding, followed by an ownership of 4.8% by the third-largest shareholder.

After doing some more digging, we found that the top 20 have the combined ownership of 50% in the company, suggesting that no single shareholder has significant control over the company.

Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. Quite a few analysts cover the stock, so you could look into forecast growth quite easily.